Oncology Scientific Advisory Board to support advancement of Immuneering’s drug programs modulating the RAS/MAPK signaling pathway in cancer CAMBRIDGE, Mass. – March 25, 2020 – Immuneering Corporation today announced…
Read More
Published: Jan 28, 2020 By Alex Keown In drug development, assets are often aimed at a specific disease target or pathway, similar to a bullet fired from a…
IMMUNEERING RAISES $20 MILLION FOR NEW DRUG-DISCOVERY EFFORT Company formed in 2008 also provides services to pharmaceutical companies By Brian Gormley Venture capitalists are betting $20 million that…
FINANCING TO FUND IMMUNEERING’S PIPELINE INCLUDING PROGRAMS IN CANCER CACHEXIA, NEXT-GENERATION KRAS INHIBITION AND THE RAF-MEK PATHWAY, ALL DRIVEN BY ITS DISEASE CANCELLING TECHNOLOGY CAMBRIDGE, Mass. – Jan. 22,…
On this episode of The Bio Report podcast Immuneering co-founder and CEO Ben Zeskind discusses the company’s evolution from its roots in bioinformatics, movement into drug development, and the proprietary…
INDUSTRY VETERAN JOINS EXECUTIVE TEAM AS IMMUNEERING ADVANCES RAPIDLY GROWING PIPELINE OF CANCER MEDICINES DRIVEN BY DISEASE CANCELLING TECHNOLOGY CAMBRIDGE, Mass. – Dec. 19, 2019 – Immuneering Corporation today…
FUNDING TO ADVANCE RAPIDLY-GROWING PIPELINE OF CANCER MEDICINES DRIVEN BY DISEASE CANCELLING TECHNOLOGY AND EXPAND SERVICES BUSINESS CAMBRIDGE, Mass. – Dec. 16, 2019 – Immuneering Corporation today announced the…
Immuneering to Present at the 12th International Conference on Cachexia, Sarcopenia & Muscle Wasting
CAMBRIDGE, Mass., Dec. 04, 2019 (GLOBE NEWSWIRE) — Immuneering today announced the company’s participation in the 12th International Conference on Cachexia, Sarcopenia & Muscle Wasting taking place in Berlin, Dec. 6-8,…
Excerpt from Chapter 1 – Computational Toxicology Promotes Regulatory Science: New tools have become available to researchers and regulators including genomics, transcriptomics, proteomics, machine learning, artificial intelligence, molecular dynamics, bioinformatics,…
Toxicant screening is only as efficient and effective as the underlying methods. Unfortunately, chemical toxicity screening is predominated by slow, laborious, and costly methods some of which raise ethical concerns….
